Abstract
(BJOG. 2016;123:1143–1151) The Control of Hypertension In Pregnancy Study (CHIPS trial) investigated the impact of a target blood pressure (BP) on maternal and perinatal outcomes by randomizing women with gestational or preexisting hypertension to a diastolic BP target of 100 (“less tight” control group) versus 85 mm Hg (“tight” control group). The present study, a secondary analysis of the CHIPS trial data, aimed to compare pregnancy outcomes between women taking methyldopa or labetalol while considering the allocation of these patients to the “less tight” or “tight” control group.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
